Inal, A. Et Al. 2012. Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study. NEOPLASMA , vol.59, no.3 , 297-301.

Inal, A., Kos, F. T., Algin, E., Yildiz, R., Dikiltas, M., Unek, I. T., ... Colak, D.(2012). Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study. NEOPLASMA , vol.59, no.3, 297-301.

Inal, A. Et Al. "Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study," NEOPLASMA , vol.59, no.3, 297-301, 2012

Inal, A. Et Al. "Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study." NEOPLASMA , vol.59, no.3, pp.297-301, 2012

Inal, A. Et Al. (2012) . "Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study." NEOPLASMA , vol.59, no.3, pp.297-301.

@article{article, author={A. Inal Et Al. }, title={Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study}, journal={NEOPLASMA}, year=2012, pages={297-301} }